Cipla announces a significant 30% increase in net profit and 9% revenue growth for Q4, with an 8% annual revenue rise to Rs 27,548 crore. Leadership remains optimistic about future...
Biogen Inc. reports a 6% revenue increase to $2.4 billion in Q1 2025, despite a dip in earnings per share. CEO Christopher Viehbacher emphasizes the strategic shift towards diversi...
Biogen Inc. reported a 6% increase in Q1 2025 revenue to $2.4 billion, despite a drop in GAAP diluted EPS to $1.64. CEO Christopher Viehbacher highlights the strategic growth and d...
Biogen Inc. reports a 6% revenue growth to $2.4 billion in Q1 2025, with a notable shift in revenue sources outside its MS business, despite a decrease in GAAP earnings per share.
GSK plc announced a 2% increase in Q1 sales, totaling £6.95 billion, demonstrating resilience in a challenging market. More updates on their performance and strategies are forthcom...
AstraZeneca announces a 7% revenue increase to $13.6 billion in Q1 2025, with product sales up by 6% to $12.9 billion. The company forecasts continued growth, aiming for $80 billio...
AstraZeneca PLC has announced a 7% increase in Q1 revenue for 2025, reaching $13.6 billion, showcasing its strong performance in the pharmaceutical industry.
Novartis achieves a 40% EPS growth in Q1, reaching $1.83, showcasing strong performance and strategic growth in the pharmaceutical sector. More details to follow.
Sanofi SA reports a 10.8% annual increase in Q1 2025 net sales to €9.9 billion, with significant growth in net income and EPS, reaffirming its positive outlook for 2025.
Roche reports a 6% increase in Q1 sales, totaling 15.4 billion Swiss francs, indicating strong market performance and strategic success in the pharmaceutical industry.
Novartis and Sanofi CEOs have urged the EU to increase drug prices, warning of the region's pharmaceutical sector decline. They propose measures like EU-wide list prices and spendi...
India's pharmaceutical sector benefits from US tariff exemptions, highlighting the global importance of its generic medicines. This decision strengthens India-US trade relations an...
Sun Pharma, India's leading drug maker, appoints Aalok Shanghvi as COO, signaling a strong succession plan and commitment to future growth under the guidance of the next generation...
Granules India Ltd reports a 6% drop in Q3 PAT to Rs 117.6 crore due to the temporary closure of its Gagillapur facility following USFDA observations, impacting revenues and profit...
